Almeida Capital is pleased to be a premier sponsor of AltAssets
AltAssets HomeAlmeida Capital websiteAlmeida Capital

 

PRINT THIS PAGE

Blackstone-led private equity consortium bids £1.5bn for UK drug group

22/09/2004Source: AltAssets.  

Click here for the latest news, views and interviews in the clean energy investor communityA private equity consortium led by Blackstone Group has tabled an offer of £1.5bn for UK drug group Warner Chilcott. Shares in the women's healthcare specialist surged 15 per cent to 747p as the company confirmed the bid.

Blackstone declined to comment on the takeover approach but the firm is understood to be interested in Warner Chilcott's near-off-patent drug business, according to a report by The Times. Blackstone failed in its attempt to buy a similar business from French pharmaceutical group Aventis earlier this year.

Two other private equity firms are believed to be involved in the consortium but the identity of the participants has not yet been revealed.

Copyright © 2004 AltAssets

top of the page

  Advanced Search

HOME | ABOUT US | CONTRIBUTE | FAQ | ADVERTISING | RSS FEED | WEEKLY NEWSLETTER SIGN-UP | CONTACT US

All rights reserved. This document and its content are for your personal, non-commercial use only. No further copying, reproduction, distribution, transmission, display of AltAssets content is allowed. To obtain permission please contact editorial@altassets.com. You may not alter or remove the copyright or any other statements from copies of the content.

AltAssets Limited is registered in UK (04210936). Available online at www.AltAssets.net
Registered Office: Burleigh House, 357 Strand, London WC2R 0HS, United Kingdom. Legals & Terms of Use
Content is © AltAssets 2000-2009

Subscribe to our newsletter Subscribe to our newsletter Recent news itemsNews archive